The Canadian Cancer Society (CCS) and the Creative Destruction Lab (CDL) have launched a new world-class accelerator program for entrepreneurs and researchers developing innovations to improve the cancer experience globally and throughout the cancer care continuum. This program will educate, coach, finance and inspire seed-stage oncology-focused companies by pairing them with mentors, industry leaders and subject matter experts. Over 9 months and 5 sessions, accepted startups will be supporte... Read More »
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »